Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate COVID-19-infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04627584
What this trial is testing

Clinical Trial of MW33 Injection in Patients With COVID-19

Who this might be right for
Covid19
Mabwell (Shanghai) Bioscience Co., Ltd. 150
Testing effectiveness (Phase 2)Study completedNCT04374149
What this trial is testing

Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS

Who this might be right for
Cytokine Release SyndromeCOVID19
Prisma Health-Upstate 20
Testing effectiveness (Phase 2)Ended earlyNCT05195749
What this trial is testing

A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care

Who this might be right for
COVID-19
101 Therapeutics 3
Large-scale testing (Phase 3)WithdrawnNCT05552625
What this trial is testing

The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Helixmith Co., Ltd.
Not applicableStudy completedNCT04716647
What this trial is testing

Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research

Who this might be right for
Covid19
Aarogyam UK 28
Testing effectiveness (Phase 2)Ended earlyNCT04416048
What this trial is testing

Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

Who this might be right for
COVID-19
Charite University, Berlin, Germany 111
Not applicableStudy completedNCT05328479
What this trial is testing

Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in Thailand

Who this might be right for
COVID-19
Mahidol University 5,181
Testing effectiveness (Phase 2)Study completedNCT04932941
What this trial is testing

MP1032 Treatment in Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19
MetrioPharm AG 132
Not applicableStudy completedNCT04686760
What this trial is testing

Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients

Who this might be right for
Corona Virus Infection
University of Lahore 278
Testing effectiveness (Phase 2)UnknownNCT04840459
What this trial is testing

Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting

Who this might be right for
Covid19
Sohail Rao 1,000
Not applicableStudy completedNCT06636760
What this trial is testing

Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients Recovery

Who this might be right for
COVID 19
Universitas Indonesia 66
Testing effectiveness (Phase 2)Ended earlyNCT04530617
What this trial is testing

Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients

Who this might be right for
Covid19DiabetesHypertension+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 246
Not applicableStudy completedNCT04603690
What this trial is testing

Oral Curcumin, Quercetin and Vitamin D3 Supplements for Mild to Moderate Symptoms of COVID-19

Who this might be right for
Covid-19
Liaquat University of Medical & Health Sciences 50
Large-scale testing (Phase 3)UnknownNCT05056558
What this trial is testing

Efficacy and Safety of Baricitinib in Patients With Moderate and Severe COVID-19

Who this might be right for
Covid19
Incepta Pharmaceuticals Ltd 480
Not applicableEnded earlyNCT04322279
What this trial is testing

Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19.

Who this might be right for
Coronavirus
Institut National de la Santé Et de la Recherche Médicale, France 81
Not applicableEnded earlyNCT05059080
What this trial is testing

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study

Who this might be right for
COVID-19Long COVID
Hoffmann-La Roche 72
Testing effectiveness (Phase 2)Study completedNCT04453384
What this trial is testing

Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia

Who this might be right for
SARS Virus
Nantes University Hospital 416
Not applicableUnknownNCT05374772
What this trial is testing

A Retrospective Study in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Shanghai Pudong Hospital 300
Testing effectiveness (Phase 2)UnknownNCT05047783
What this trial is testing

Masitinib in Patients With Symptomatic Mild to Moderate COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionCoronavirus Disease 2019
AB Science 78
Post-approval studies (Phase 4)Study completedNCT04709172
What this trial is testing

Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia

Who this might be right for
COVID-19 Pneumonia
Meiji Pharma Spain S.A. 20
Next Page